EmboBio Medical Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
EmboBio Medical General Information
Description
Developer of a biological embolizing agent designed for interventional radiology. The company's technology utilizes eco-friendly biological materials to block blood flow during minimally invasive surgery, enabling medical professionals to treat tumors and hemorrhages with a sustainable and cost-effective alternative to synthetic agents.
Contact Information
Corporate Office
- Impasse Gallet Cantant
- 13080 Aix-en-Provence
- France
Corporate Office
- Impasse Gallet Cantant
- 13080 Aix-en-Provence
- France
EmboBio Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup |
EmboBio Medical Signals
EmboBio Medical Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Incubateur Impulse | Accelerator/Incubator |
EmboBio Medical FAQs
-
When was EmboBio Medical founded?
EmboBio Medical was founded in 2022.
-
Where is EmboBio Medical headquartered?
EmboBio Medical is headquartered in Aix-en-Provence, France.
-
What is the size of EmboBio Medical?
EmboBio Medical has 3 total employees.
-
What industry is EmboBio Medical in?
EmboBio Medical’s primary industry is Surgical Devices.
-
Is EmboBio Medical a private or public company?
EmboBio Medical is a Private company.
-
What is EmboBio Medical’s current revenue?
The current revenue for EmboBio Medical is .
-
Who are EmboBio Medical’s investors?
Incubateur Impulse has invested in EmboBio Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process